Cancer Research Meeting Calendar  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Offer, H.
Right arrow Articles by Rotter, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Offer, H.
Right arrow Articles by Rotter, V.
[Cancer Research 61, 88-96, January 1, 2001]
© 2001 American Association for Cancer Research


Carcinogenesis

p53 Modulates Base Excision Repair Activity in a Cell Cycle-specific Manner after Genotoxic Stress1

Hagai Offer, Irit Zurer, Gaspar Banfalvi, Marian Reha’k, Ayellet Falcovitz, Michael Milyavsky, Naomi Goldfinger and Varda Rotter2

Departments of Molecular Cell Biology [H. O., I. Z., A. F., M. M., N. G., V. R.] and Biological Chemistry [G. B., M. R.], Weizmann Institute of Science, Rehovot 76100, Israel

To elucidate the nature of the cross-talk between the p53 protein and the DNA repair machinery, we have investigated the relationship between the two throughout the cell cycle. Base excision repair (BER) was analyzed in cell cycle phase-enriched populations of lymphoid cells expressing wild-type p53. Our study yielded the following novel findings: (a) BER exhibited two distinct peaks of activity, one associated with the G0-G1 checkpoint and the second with the G2-M checkpoint; (b) although the overall BER activity was reduced after exposure of cells to 400R, there was an augmentation of the G0-G1-associated BER activity and a reduction in the G2-M-associated BER activity; and (c) modulations in these patterns of BER after genotoxic stress were found to be p53 regulated. p53 protein levels induced after {gamma}-irradiation were distributed evenly in the various cell cycle populations (analyzed by the PAb-248 anti-p53 monoclonal antibody). However, both the dephosphorylation of serine 376 of p53 (contained in the PAb-421 epitope) and the specific DNA binding activity, as well as apoptosis, were enhanced toward the G2-M populations. Furthermore, inactivation of wild-type p53, mediated by mutant p53 expression, abolished the alterations in the BER pattern and showed no induction of a G2-M-associated apoptosis after {gamma}-irradiation. These results suggest that after genotoxic stress, stabilized p53 enhances the G0-G1-associated BER activity, whereas it predominantly reduces BER activity at the G2-M-enriched populations and instead induces apoptosis. After genotoxic stress, p53 functions as a modulator that determines the pattern of BER activity and apoptosis in a cell cycle-specific manner.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
S. M. K. Pulukuri, J. A. Knost, N. Estes, and J. S. Rao
Small Interfering RNA-Directed Knockdown of Uracil DNA Glycosylase Induces Apoptosis and Sensitizes Human Prostate Cancer Cells to Genotoxic Stress
Mol. Cancer Res., August 1, 2009; 7(8): 1285 - 1293.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
S. N. Kassam and A. J. Rainbow
UV-inducible base excision repair of oxidative damaged DNA in human cells
Mutagenesis, January 1, 2009; 24(1): 75 - 83.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. Menendez, A. Inga, and M. A. Resnick
The Biological Impact of the Human Master Regulator p53 Can Be Altered by Mutations That Change the Spectrum and Expression of Its Target Genes.
Mol. Cell. Biol., March 1, 2006; 26(6): 2297 - 2308.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Wu, J. A. Roth, H. Zhao, S. Luo, Y.-L. Zheng, S. Chiang, and M. R. Spitz
Cell Cycle Checkpoints, DNA Damage/Repair, and Lung Cancer Risk
Cancer Res., January 1, 2005; 65(1): 349 - 357.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N. Sugo, N. Niimi, Y. Aratani, K. Takiguchi-Hayashi, and H. Koyama
p53 Deficiency Rescues Neuronal Apoptosis but Not Differentiation in DNA Polymerase {beta}-Deficient Mice
Mol. Cell. Biol., November 1, 2004; 24(21): 9470 - 9477.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
I. Zurer, L. J. Hofseth, Y. Cohen, M. Xu-Welliver, S. P. Hussain, C. C. Harris, and V. Rotter
The role of p53 in base excision repair following genotoxic stress
Carcinogenesis, January 1, 2004; 25(1): 11 - 19.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. L. Scott, J. D. Earle, and P. H. Gumerlock
Functional p53 Increases Prostate Cancer Cell Survival After Exposure to Fractionated Doses of Ionizing Radiation
Cancer Res., November 1, 2003; 63(21): 7190 - 7196.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
N. K. Sah, A. Munshi, T. Nishikawa, T. Mukhopadhyay, J. A. Roth, and R. E. Meyn
Adenovirus-mediated wild-type p53 radiosensitizes human tumor cells by suppressing DNA repair capacity
Mol. Cancer Ther., November 1, 2003; 2(11): 1223 - 1231.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. R. Lloyd and P. C. Hanawalt
p53 Controls Global Nucleotide Excision Repair of Low Levels of Structurally Diverse Benzo(g)chrysene-DNA Adducts in Human Fibroblasts
Cancer Res., September 15, 2002; 62(18): 5288 - 5294.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Liu, Y. Nakatsuru, and S. L. Gerson
Base Excision Repair as a Therapeutic Target in Colon Cancer
Clin. Cancer Res., September 1, 2002; 8(9): 2985 - 2991.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Offer, N. Erez, I. Zurer, X. Tang, M. Milyavsky, N. Goldfinger, and V. Rotter
The onset of p53-dependent DNA repair or apoptosis is determined by the level of accumulated damaged DNA
Carcinogenesis, June 1, 2002; 23(6): 1025 - 1032.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
M. L. Smith and Y. R. Seo
p53 regulation of DNA excision repair pathways
Mutagenesis, March 1, 2002; 17(2): 149 - 156.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. M. d. M. C. Gontijo, F. N. Elias, D. M. F. Salvadori, M. L. C. S. de Oliveira, L. A. Correa, J. Goldberg, J. C. d. S. Trindade, and J. L. V. de Camargo
Single-Cell Gel (Comet) Assay Detects Primary DNA Damage in Nonneoplastic Urothelial Cells of Smokers and Ex-smokers
Cancer Epidemiol. Biomarkers Prev., September 1, 2001; 10(9): 987 - 993.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. Frosina
Counteracting spontaneous transformation via overexpression of rate-limiting DNA base excision repair enzymes
Carcinogenesis, September 1, 2001; 22(9): 1335 - 1341.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.